Is hormone therapy used for HER2-Positive Breast Cancer and how does it work
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Hormone Therapy for HER2-Positive Breast Cancer
Great question! The answer depends on whether your HER2-positive cancer is also hormone receptor-positive (HR+), which is an important distinction.
When Hormone Therapy IS Used
If you have HR+ with HER2+ (also called triple-positive breast cancer):
Yes, hormone therapy IS used as part of your treatment plan. According to the NCCN Guidelines for Patients: Invasive Breast Cancer, when cancer is both hormone receptor-positive AND HER2-positive, treatment includes:
- HER2-targeted therapy (the primary focus) - drugs like trastuzumab and pertuzumab
- Chemotherapy (usually given first)
- Endocrine (hormone) therapy (given after chemotherapy)
The NCCN guidelines specifically state that "endocrine therapy is used to treat HR+ breast cancer" and is given after chemotherapy in triple-positive cases.
How Hormone Therapy Works
Hormone therapy blocks estrogen or progesterone from fueling cancer growth. Here are the main approaches:
Blocking Estrogen Production:
- Aromatase inhibitors (AIs) like anastrozole (Arimidex) and letrozole (Femara) stop the enzyme that converts other hormones into estrogen
- These work best in postmenopausal women
Blocking Hormone Receptors:
- Tamoxifen and similar drugs prevent estrogen from attaching to cancer cell receptors (like putting a lock on the door so the hormone can't enter)
Ovarian Suppression (for premenopausal women):
- Drugs like goserelin (Zoladex) temporarily stop the ovaries from making hormones
- May be combined with other hormone therapies
If You Have HR- with HER2+ (Hormone Receptor-Negative)
If your cancer is NOT hormone receptor-positive, hormone therapy is NOT used. Treatment focuses entirely on HER2-targeted therapy, since there are no hormone receptors to target.
Important Questions to Ask Your Oncologist
- Is my cancer HR+ or HR-? This determines whether hormone therapy is part of my plan.
- If I'm HR+, which hormone therapy option is recommended for me, and why?
- How long will I take hormone therapy, and what side effects should I expect?
- Am I pre- or postmenopausal, and does that change my treatment options?
- Will I need ovarian suppression in addition to other hormone therapy?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for HER2-Positive Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: